Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
Q3 bank reporting season takes centre stage. UnitedHealth Group opens Monday's proceedings, with Johnson & Johnson following Tuesday before the bell. The bank roll-call runs Wednesday through Friday: Bank of America, State Street, BNY, Charles Schwab, Truist Financial and Regions Financial all report. Options markets are already pricing in stress. Put bets on BAC are elevated heading into the print. BAC's RSI sits at just 31.8, and Truist carries a 5.8-day DTC, high for a money-centre bank.
Bears are building positions across crypto miners. MARA short interest reached 27.6% of free float as of 8 October. CleanSpark sits at 32.7%. Wolfspeed is the most extreme reading in the market, with short interest climbing to 84.2% of free float from 80.5% a week ago. Chip names are drawing two-way options flows. Micron Technology tops both the positive and negative bets rankings, up 261% year-to-date. Advanced Micro Devices is close behind at 184%.
Sell-side opinion split sharply on Estée Lauder. The stock now has 15 sell ratings and zero buys. PepsiCo moved the other way, gaining a consensus upgrade to buy, though Citi trimmed its target to $135 from $142 on volume pressure in North America.
ORTEX Index Rebalance Radar flags up to $1.9B of forced selling in Canadian names. Anglo American's agreed acquisition of Teck Resources carries an 88% completion probability. If it closes, ORTEX forecasts TSX 60 and S&P/TSX Composite deletions totalling $1.9B of selling pressure across 12.5 days of normal volume. A separate First Capital REIT deletion carries 80% odds, triggering $103M more.
Finnish battery-electric car registrations hit a record for September, up 68% year on year to 4,337 units, according to ORTEX alt data. Korean airports logged their largest September passenger count on record, with 38.8 million travellers, a tailwind for names like Delta Air Lines.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.